Status of antiviral immunity in patients with non-alcoholic liver fatty disease, who were Chornobyl NPP accident liquidators

Authors

  • A.A. Chumak State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • O.V. Nosach State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • E.O. Sarkisova State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • O.V. Gasanova State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • L.M. Ovsyannikova State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • O.Ya. Pleskach State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • S.M. Alokhina State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • V.I. Shynkarenko State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
  • T.I. Shyiko State Institution “National Research Centre for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,

DOI:

https://doi.org/10.22141/2312-413x.5.6.2017.122143

Keywords:

Herpesviridae family viruses, non-alcoholic fatty liver disease, Chornobyl NPP accident liquidators

Abstract

34 men were examined, who after participating in the liquidation of the Chornobyl NPP accident developed non-alcoholic fatty liver disease. The state of antiviral defense was evaluated by the levels of immunoglobulin (Ig) G and IgM antibodies in the blood serum. In most patients with non-alcoholic steatohepatitis, who were Chornobyl NPP accident liquidators, antibodies of the IgG, but not IgM class to the persistent mixed infection with herpes simplex virus types 1 and 2, cytomegaly and Epstein-Barr were found. A positive correlation was established between the antibody titers to the herpes simplex virus types 1 and 2 (anti-HSV-1/2 IgG) and cytomegalovirus (anti-CMV IgG) (rs = 0.383, p = 0.040), as well as between the antibodies titers to the nuclear antigen of Epstein-Barr virus (anti-EBV NA IgG) and antibodies to core antigen of Epstein-Barr (anti-EBV VCA IgG) (rs = 0.584, p = 0.002) in patients with persistent mixed infection of these herpesviruses.

References

Carr RM, Oranu A, Khungar V. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Gastroenterol Clin North Am. 2016 Dec;45(4):639-652. doi: 10.1016/j.gtc.2016.07.003.

Xu R, Tao A, Zhang S, Deng Y, Chen G. Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis. Sci Rep. 2015 Mar 20;5:9284. doi: 10.1038/srep09284.

Marinkin IO, Zhurakovskii IP, Pustovetova MG, Kunts TA, Bitkhaeva MV, Shanturova TV. Sposob profilaktiki porazheniia pecheni pri formirovanii sindroma sochetannykh distroficheski-degenerativnykh izmenenii mezenkhimal'nykh proizvodnykh pri lokal'nom khronicheskom vospalitel'nom protsesse i sredstvo dlia ego osushchestvleniia [Method for preventing liver damage in the formation of the syndrome of combined dystrophic and degenerative changes of mesenchymal derivatives in a local chronic inflammatory process and a means for its implementation]. Patent 2455988 RU, 2012. (in Russian).

Grinde B. Herpesviruses: latency and reactivation – viral strategies and host response. J Oral Microbiol. 2013;5:10.3402/jom.v5i0.22766. doi: 10.3402/jom.v5i0.22766.

Kofteridis DP, Koulentaki M, Valachis A, et al. Epstein Barr virus hepatitis. Eur J Intern Med. 2011 Feb;22(1):73-6. doi: 10.1016/j.ejim.2010.07.016.

Salva I, Silva IV, Cunha F. Epstein-Barr virus-associated cholestatic hepatitis. BMJ Case Rep. 2013 Dec 16;2013. pii: bcr2013202213. doi: 10.1136/bcr-2013-202213.

Zhang W, Chen B, Chen Y, et al. Epstein-Barr virus-associated acute liver failure present in a 67-year-old immunocompetent female. Gastroenterology Res. 2016 Oct;9(4-5):74-78. doi: 10.14740/gr718e.

Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):425-438. doi: 10.1080/17425255.2017.1252749.

Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010 Jul;20(4):202-13. doi: 10.1002/rmv.655.

Shen JH, Huang KY, Chao-Yu C, Chen CJ, Lin TY, Huang YC. Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007. PLoS One. 2015 Aug 7;10(8):e0134178. doi: 10.1371/journal.pone.0134178.

Conde-Glez C, Lazcano-Ponce E, Rojas R, et al. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine. 2013 Oct 17;31(44):5067-74. doi: 10.1016/j.vaccine.2013.08.077.

Ogunjimi B, Theeten H, Hens N, Beutels P. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation. J Med Virol. 2014 May;86(5):812-9. doi: 10.1002/jmv.23749.

Schoenfeld J, Cannon S, Cam K, Keller M. Cutaneous Co-infected Cytomegalovirus and Herpes Simplex Virus Perigenital Ulcers in Human Immunodeficiency Virus Patients. J Clin Aesthet Dermatol. 2013 Oct;6(10):41-3. PMID: 24155993.

Gusev EY, Chereshnev VA, Yurchenko LN. Systemic inflammation as a typical pathological process. Cytokines and Inflammation. 2007;6(4):9-21. (in Russian).

Iulish EI. Paradigm of formation and development of chronic somatic diseases against persistent infections. Zdorov'ye Rebenka. 2010;6(27):97-103. (in Russian).

Issue

Section

Original Researches